Form 4: Twist Bioscience Executive Dennis Cho Sells Shares to Cover Tax Obligations

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 689 shares of common stock on May 5, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On May 5, 2025, Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp, sold 689 shares of common stock.
• The sale was executed at a price of $37.651 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Cho directly owns 110,849 shares of Twist Bioscience Corp.
• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (sell to cover taxes) and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. Monitoring these transactions can provide insights into executive sentiment and company performance, although 'sell to cover' transactions are typically less indicative of sentiment than discretionary sales.

Comparison to Industry Standards

• Executive compensation practices, including the use of Restricted Stock Units (RSUs) and 'sell to cover' tax strategies, are common across the biotechnology industry.
• Companies like Illumina, Agilent, and Thermo Fisher Scientific also utilize equity compensation plans that may result in similar transactions by their executives.
• The volume of shares sold and the specific circumstances (e.g., tax obligations) are typical considerations when evaluating the significance of such transactions.

Stakeholder Impact

• The transaction has minimal direct impact on stakeholders, as it is a routine sale to cover tax obligations.
• The sale does not represent a significant change in ownership or a change in the executive's commitment to the company.

Key Dates

Keywords

Twist Bioscience, TWST, Dennis Cho, SEC Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Executive, Insider Trading